Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in refractory non-infectious ocular inflammatory disease at Siriraj Hospital
TCTR20200515002Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Mar 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Single-arm trial of golimumab in ocular inflammation, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Mar 2019; status: completed.
02
Drugs
golimumab
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on TCTR20200515002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200515002.